慢性肝病血流动力学变化的量化:灌注CT数据与纤维化组织病理学分期的相关性
本回顾性研究纳入41例肝移植或肝切除术前患者,采用灌注CT测量动脉性肝灌注、门静脉性灌注及肝灌注指数,并与Ishak纤维化分期及AST-血小板比值指数相关。结果显示门静脉性灌注和肝灌注指数在肝纤维化(F3)与不完全性肝硬化(F5)及完全性肝硬化(F6)间差异有统计学意义,而动脉性肝灌注组间差异无统计学意义。结论认为灌注CT定量数据可用于区分肝纤维化(F3)与肝硬化(F5/F6)。
要点
- 门静脉性灌注在Ishak F3组高于F5组和F6组,肝灌注指数则呈相反方向。
- 动脉性肝灌注在各纤维化分期组间差异无统计学意义(F=3,p=0.15)。
- 灌注CT参数与AST-血小板比值指数、MELD评分及Child-Pugh评分均无相关性。
核心结论
- 灌注CT定量数据可用于区分肝纤维化(Ishak F3)与肝硬化(Ishak F5/F6)。
研究设计与样本
- 回顾性研究,纳入2013年至2016年间肝移植或肝切除术前接受灌注CT检查的41例连续患者(Child-Pugh A级19例、B级17例、C级5例;MELD评分范围7至28)。
诊断标准与关键数值
- 门静脉性灌注:F3组69.5±23.7 ml/100 ml/min vs F5组52.9±25.7 ml/100 ml/min vs F6组46.4±24.8 ml/100 ml/min(范围6.3-112.0 ml/100 ml/min;F=15,p<0.0001)。
临床应用与阅片要点
- 阅片时可关注门静脉性灌注和肝灌注指数的组间差异模式,动脉性肝灌注在各期纤维化间未见显著差异。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
RATIONALE AND OBJECTIVES: To noninvasively estimate the severity of liver fibrosis using perfusion-CT (PCT)-based quantification of dual liver blood supply prior to liver transplantation or liver resections and to correlate results with histological grading of fibrosis stages and AST-platelet ratio index.
MATERIALS AND METHODS: Institutional review board approved this retrospective study. We analysed 41 consecutive patients (19 classified as Child-Pugh A, 17 as Child-Pugh B, and 5 as Child-Pugh C; MELD score ranged from 7 to 28) who underwent PCT prior to liver transplantation/liver resections between 2013 and 2016. The examination protocol included a scan time of 40 s, 80 kV, 100/120 mAs. Arterial liver perfusion, portal-venous perfusion and hepatic perfusion index (HPI) were registered in liver parenchyma by three readers. Fibrosis was histological graded according to Ishak scoring system as liver fibrosis (F3, n = 10), incomplete liver cirrhosis (F5, n = 5), and complete liver cirrhosis (F6, n = 26).
RESULTS: Portal-venous perfusion was significantly higher in liver fibrosis (F3 69.5±23.7 ml/100 ml/min) compared to incomplete liver cirrhosis (F5, 52.9±25.7 ml/100 ml/min) and complete liver cirrhosis (F6, 46.4±24.8 ml/100 ml/min (range 6.3-112.0 ml/100 ml/min; F = 15, p < 0.0001). HPI showed the same group differences (F = 20, p < 0.0001; HPI F3: 19.1±10.7%, HPI F5: 38.5±24.3%, HPI F6: 43.4±25.8%). Group comparisons were not significant for arterial liver perfusion (F = 3, p = 0.15). PCT parameters as well as histological fibrosis grading did neither correlate with laboratory findings including AST-platelet ratio index and MELD-Score, nor with Child-Pugh-Score.
CONCLUSION: Quantitative data from perfusion-CT can be used to differentiate between liver fibrosis (F3) and liver cirrhosis (F5/F6).
引用
- Wm T, L S, C K, et al. Quantification of Hemodynamic Changes in Chronic Liver Disease: Correlation of Perfusion-CT Data with Histopathologic Staging of Fibrosis. Acad Radiol. 2018. PMID: 30528750. doi:10.1016/j.acra.2018.11.009
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。